This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert W. Martin III, MD; Evan R. Farmer, MD; Viki L. Altomonte, RN; Georgia B. Vogelsang, MD; George W. Santos, MD

Arch Dermatol. 1995;131(3):333-335.

Abstract
Background
Graft-vs-host disease (GVHD) represents one of the major complications of allogeneic bone marrow transplantation (BMT) but is less common in autologous BMT. Following autologous BMT, chronic GVHD has been reported in only four patients, all of whom had a self-limited sclerodermoid form. Lichenoid chronic GVHD has not been previously reported in an autologous BMT patient.

Observations
Mucosal and cutaneous lichenoid lesions and histologic findings compatible with chronic lichenoid GVHD developed in a patient 35 days after autologous BMT was performed. The onset of clinical lesions at 35 days after BMT is not incongruent with the diagnosis of chronic lichenoid GVHD (rather than a graft-vs-host reaction) and may have been augmented by cyclosporin A in a manner similar to animal model experiments.

Conclusion
All forms of GVHD can and do occur following autologous BMT.

(Arch Dermatol. 1995;131:333-335)

Author Affiliations
From the Departments of Dermatology (Drs Martin and Farmer) and Oncology (Ms Altomonte and Drs Vogelsang and Santos), The Johns Hopkins University School of Medicine, Baltimore, Md. Drs Martin and Farmer are now with the Cutaneous Pathology and Immunofluorescence Laboratory, Beachwood, Ohio, and the Indiana University School of Medicine, Indianapolis, respectively.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?